Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
The Receivables Turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by average Accounts Receivable. An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. Balaji Amines's Revenue for the
three
months ended in Mar. 2026 was ₹3,948 Mil. Balaji Amines's average Accounts Receivable for the
three
months ended in Mar. 2026 was ₹3,459 Mil.
Hence, Balaji Amines's Receivables Turnover for the
three
months ended in Mar. 2026 was 1.14.
An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. This metric is commonly used to compare companies within the same industry to check whether they are on par with their competitors.
Balaji Amines Receivables Turnover Related Terms
Balaji Amines Receivables Turnover Historical Data
* Premium members only.
The historical data trend for Balaji Amines's Receivables Turnover can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
NSE:BALAMINES vs LIN, SHW, ECL: Receivables Turnover Comparison
For the Specialty Chemicals subindustry, Balaji Amines's Receivables Turnover, along with its competitors' market caps and Receivables Turnover data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Balaji Amines Receivables Turnover vs Chemicals Industry
For the Chemicals industry and Basic Materials sector, Balaji Amines's Receivables Turnover distribution charts can be found below:
* The bar in red indicates where Balaji Amines's Receivables Turnover falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Balaji Amines (NSE:BALAMINES) has a Receivables Turnover of 1.14 as of Mar. 2026. The accounts receivables turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by Average Accounts Receivable. View historical data on Balaji Amines and its competitors. According to the industry distribution chart, Balaji Amines ranks #1029 out of 1577 companies in the Chemicals industry, placing it in the top 65.3%.
Is Balaji Amines' Receivables Turnover too high?
Balaji Amines' current Receivables Turnover is 1.14. The Chemicals industry median Receivables Turnover is 5.59. Balaji Amines' value of 1.14 is 79.6% below this industry median. Based on the distribution chart, Balaji Amines ranks #1029 out of 1577 companies in the Chemicals industry, which is below the industry midpoint. Overall, Balaji Amines has a GF Score™ of 78/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Balaji Amines' Receivables Turnover compare to LIN and SHW?
According to the Chemicals industry distribution chart, Balaji Amines ranks #1029 out of 1577 companies for Receivables Turnover. This places Balaji Amines in the lower half of its industry. The industry median Receivables Turnover is 5.59. Balaji Amines' value of 1.14 is 79.6% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Receivables Turnover for a Chemicals company?
The median Receivables Turnover among Chemicals companies is 5.59, based on 1,577 companies in the industry. Companies in the top quartile (top 25%) have a Receivables Turnover significantly above this median, while those in the bottom quartile fall well below. However, Receivables Turnover should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Balaji Amines's current Receivables Turnover of 1.14 is 79.6% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Receivables Turnover mean?
A high Receivables Turnover can signal that a stock is expensive relative to its fundamentals. The accounts receivables turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by Average Accounts Receivable. View historical data on Balaji Amines and its competitors. For the Chemicals industry, the median Receivables Turnover is 5.59 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Balaji Amines's current Receivables Turnover is 1.14. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Balaji Amines stock overvalued right now?
Based on GuruFocus' analysis, Balaji Amines (NSE:BALAMINES) is currently considered Significantly Overvalued. The stock's GF Value™ is ₹1,662.89, compared to a current price of ₹2,314.20 — trading 39.2% above its estimated fair value. The current Receivables Turnover is 1.14 and 79.6% below the Chemicals industry median of 5.59. Balaji Amines' overall GF Score™ is 78/100 with 9 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Receivables Turnover calculated?
Receivables Turnover is calculated from a company's financial statements. For Balaji Amines (NSE:BALAMINES), the current Receivables Turnover is 1.14 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Balaji Amines (NSE:BALAMINES) Overvalued in 2026?
Based on GuruFocus' analysis, Balaji Amines stock appears to be overvalued.
The current stock price of ₹2,314.20 is trading 39.2% above its estimated GF Value™ of ₹1,662.89.
GuruFocus considers Balaji Amines to be Significantly Overvalued.
Key valuation signals for NSE:BALAMINES:
Receivables Turnover: 1.14
GF Value™: ₹1,662.89 vs. price of ₹2,314.20 (39.2% above fair value)
Industry Position: 79.6% below the Chemicals median (#1029 of 1577)
No single metric tells the full story. See the NSE:BALAMINES stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Balaji Amines Ltd is engaged in the manufacture and sale of aliphatic amines, speciality chemicals, and their derivatives. The Company's manufacturing facilities operate through Distributed Control Systems (DCS), indigenous process technologies, and a Zero Liquid Discharge (ZLD) framework. The business operates through the Chemicals and Hotel segments, with the Chemicals segment generating maximum revenue. Its products include amines such as Mono Methyl Amine (MMA), Di-Methyl Amine (DMA) and others; speciality chemicals such as Morpholine, Acetonitrile (ACN), and others; and amine derivatives such as Mono-Methyl Amine Hydrochloride (MMA HCL), Di-Methyl Amine Hydrochloride (DMA HCL) and others. Geographically, the Company generates maximum revenue from India.
78GF Score
Get the complete analysis for NSE:BALAMINES
Receivables Turnover is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:BALAMINES has been successfully added to your 
